132 related articles for article (PubMed ID: 25973563)
1. Impact of Postreconstitution Room Temperature Storage on the Efficacy of IncobotulinumtoxinA Treatment of Dynamic Lateral Canthus Lines.
Soares DJ; Dejoseph LM; Zuliani GF; Liebertz DJ; Patel VS
Dermatol Surg; 2015 Jun; 41(6):712-7. PubMed ID: 25973563
[TBL] [Abstract][Full Text] [Related]
2. Commentary on Impact of Postreconstitution Room Temperature Storage on the Efficacy of IncobotulinumtoxinA Treatment of Dynamic Lateral Canthus Lines.
Lawrence N
Dermatol Surg; 2015 Jun; 41(6):718-9. PubMed ID: 25993610
[No Abstract] [Full Text] [Related]
3. A Prospective, Neurophysiologic Comparative Study to Assess the Efficacy and Duration of Effect of IncobotulinumtoxinA and AbobotulinumtoxinA in the Treatment of Crow's Feet.
Saybel A; Artemenko A; Nikitin S; Kurenkov A
J Drugs Dermatol; 2015 Nov; 14(11):1291-6. PubMed ID: 26580879
[TBL] [Abstract][Full Text] [Related]
4. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
Ascher B; Rzany BJ; Grover R
Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
[TBL] [Abstract][Full Text] [Related]
6. Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials.
Baumann L; Dayan S; Connolly S; Silverberg N; Lei X; Drinkwater A; Gallagher CJ
Dermatol Surg; 2016 May; 42(5):598-607. PubMed ID: 27110893
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
Kerscher M; Rzany B; Prager W; Turnbull C; Trevidic P; Inglefield C
Dermatol Surg; 2015 Oct; 41(10):1149-57. PubMed ID: 26359996
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
Hui JI; Lee WW
Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines.
Lizarralde M; Gutiérrez SH; Venegas A
Dermatol Surg; 2007 Nov; 33(11):1328-33; discussion 1333. PubMed ID: 17958584
[TBL] [Abstract][Full Text] [Related]
11. Two different types of botulinum toxins: Is there a difference in efficacy and longevity?
Shome D; Kapoor R; Khare S
J Cosmet Dermatol; 2019 Dec; 18(6):1635-1641. PubMed ID: 31135088
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of incobotulinumtoxinA for treatment of glabellar frown lines: a post hoc pooled analysis of 2 randomized, placebo-controlled, phase 3 trials.
Jones D; Carruthers J; Narins RS; Coleman WP; Harrington L; Brandt FS; Cohen JL
Dermatol Surg; 2014 Jul; 40(7):776-85. PubMed ID: 25111351
[TBL] [Abstract][Full Text] [Related]
13. Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study.
Prager W; Bee EK; Havermann I; Zschocke I
Clin Interv Aging; 2013; 8():449-56. PubMed ID: 23650444
[TBL] [Abstract][Full Text] [Related]
14. Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.
Carruthers A; Carruthers J; Coleman WP; Donofrio L; Flynn T; Gold M; Heinz M; Harrington L; Jones D; McDaniel D; Rohrer T; Schlöbe A; Solish N; Weiss RA
Dermatol Surg; 2013 Apr; 39(4):551-8. PubMed ID: 23379292
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.
Prager W; Wissmüller E; Kollhorst B; Williams S; Zschocke I
Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of IncobotulinumtoxinA for the treatment of platysmal bands of the aging neck: an open-label, prospective pilot study.
Gubanova EI; Panova OS; Sanchez EA; Rodina MY; Starovatova PA
J Drugs Dermatol; 2013 Dec; 12(12):1461-6. PubMed ID: 24301249
[TBL] [Abstract][Full Text] [Related]
17. A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines.
Moers-Carpi M; Dirschka T; Feller-Heppt G; Hilton S; Hoffmann K; Philipp-Dormston WG; Rütter A; Tan K; Chapman MA; Fulford-Smith A
J Cosmet Laser Ther; 2012 Dec; 14(6):296-303. PubMed ID: 23057624
[TBL] [Abstract][Full Text] [Related]
18. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
Prager W; Rappl T
J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique].
Prager W; Wissmüller E; Kollhorst B; Böer A; Zschocke I
Hautarzt; 2011 May; 62(5):375-9. PubMed ID: 21503782
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin injection for facial wrinkles.
Small R
Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
